Pentair is only one year away from potentially becoming a Dividend King. The stock's performance has beaten the S&P 500 hands down over the last five years. Pentair could be appealing to investors ...

What's notable, however, is that only once during that stretch has the stock been down more than 20% in a single year -- that was back in 2022. As interest rates were on the rise and inflation was a ...

Despite strong financial results, a recent clinical setback led to a decline in the stock. The company's valuation might continue to be an issue in the near term. However, the drugmaker has excellent ...